Dragica Zendelovska

Dragica Zendelovska

Auto-generated profile, based on publicly available information

Dragica Zendelovska

Ss. Cyril and Methodius University of Skopje

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2021 in F1000Research
Verified
Journal Article
Open access
PDF file
MPMarija Petrushevska
Marija Petrushevska
DZDragica Zendelovska
Dragica Zendelovska
EAEmilija Atanasovska
Emilija Atanasovska
AEAleksandar Eftimov
Aleksandar Eftimov
Katerina SpasovskaKaterina Spasovska
Katerina Spasovska
Introduction: COVID-19 can be worsened by hyper-production of cytokines accompanied by increased level of oxidative stress. The aim of this study was to investigate the correlation between a set of cytokines and the markers of the oxidative stress. Methods: The levels of cytokines IL-2, IL-4, IL-6, IL8, IL-10, VEGF, IFN-γ, TNF-α, IL-1α, MCP-1 and EGF were determined by using High Sensitivity Evidence Investigator™ Biochip Array technology. The oxidative stress parameters (d-ROM, PAT, OS index) were measured in serum on FRAS5 analytical photometric system. Results: IL-6, IL-8, IL-10, VEGF, MCP-1 and EGF were significantly higher (p<0.05) in the patients with severe COVID-19 with increased levels of IL-2, IFN-y, TNF-α and IL-1α. The d-ROM, OS index, and PAT were significantly higher (p<0.05) in severe COVID-19 patients. IL-6 demonstrated the strongest correlation with all of the markers of the oxidative stress, d-ROM (r=0.9725, p=0.0001), PAT (r=0.5000, p=0.0001) and OS index (r=0.9593, p=0.012). Similar behavior was evidenced between IFN-y and d-ROM (r=0.4006, p=0.0001), PAT (r=0.6030, p=0.0001) and OS index (r=0.4298, p=0.012). Conclusion: The oxidative stress markers show good correlation with the tested cytokines which can be measured at the beginning of the disease in a primary care setting to predict the course of COVID-19.

1 January 2021 in Redox Report
Verified
Journal Article
Open access
EAEmilija Atanasovska
Emilija Atanasovska
MPMarija Petrushevska
Marija Petrushevska
DZDragica Zendelovska
Dragica Zendelovska
Katerina SpasovskaKaterina Spasovska
Katerina Spasovska
MSMilena Stevanovikj
Milena Stevanovikj
NLNikola Labachevski
Nikola Labachevski
COVID-19 is characterized by the presence of oxidative stress. Vitamin D status has been reviewed as one of the factors that may affect disease severity. The aim of this study was to assess the rel...

2 August 2021 in F1000Research
Verified
Journal Article
Open access
PDF file
MPMarija Petrushevska
Marija Petrushevska
DZDragica Zendelovska
Dragica Zendelovska
EAEmilija Atanasovska
Emilija Atanasovska
AEAleksandar Eftimov
Aleksandar Eftimov
Katerina SpasovskaKaterina Spasovska
Katerina Spasovska
Introduction: COVID-19 can be worsened by hyper-production of cytokines accompanied by increased level of oxidative stress. The aim of this study was to investigate the correlation between a set of cytokines and the markers of the oxidative stress. Methods: The levels of cytokines IL-2, IL-4, IL-6, IL8, IL-10, VEGF, IFN-γ, TNF-α, IL-1α, MCP-1 and EGF were determined by using High Sensitivity Evidence Investigator™ Biochip Array technology. The oxidative stress parameters (d-ROM, PAT, OS index) were measured in serum on FRAS5 analytical photometric system. Results: IL-6, IL-8, IL-10, VEGF, MCP-1 and EGF were significantly higher (p<0.05) in the patients with severe COVID-19 with increased levels of IL-2, IFN-g, TNF-a and IL-1α. The d-ROM, OS index, and PAT were significantly higher (p<0.05) in severe COVID-19 patients. IL-6 demonstrated the strongest correlation with all of the markers of the oxidative stress, d-ROM (r=0.9725, p=0.0001), PAT (r=0.5000, p=0.0001) and OS index (r=0.9593, p=0.012). Similar behavior was evidenced between IFN-g and d-ROM (r=0.4006, p=0.0001), PAT (r=0.6030, p=0.0001) and OS index (r=0.4298, p=0.012). Conclusion: The oxidative stress markers show good correlation with the tested cytokines which can be measured at the beginning of the disease in a primary care setting to predict the course of COVID-19.

19 May 2023 in Free Radical Biology and Medicine
Verified
Journal Article
Open access
DZDragica Zendelovska
Dragica Zendelovska
MPMarija Petrushevska
Marija Petrushevska
IAIvana Arnaudova
Ivana Arnaudova
EAEmilija Atanasovska
Emilija Atanasovska

11 October 2024
Verified
Preprint
Open access
PDF file
MPMarija Petrushevska
Marija Petrushevska
DZDragica Zendelovska
Dragica Zendelovska
EAEmilija Atanasovska
Emilija Atanasovska
Good Clinical Practice (GCP) compliance delivers assurance that the study participants' safety is protected and that the obtained data are legitimate and credible. One of the tools to obtain quality in clinical research is to assure robust quality assurance and quality control as part of the quality management system. This is considered essential for sponsors to assure that the data from the clinical trial have integrity and reliability. One of the purposes of this article was to provide information to allow clinical research, quality assurance professionals, academics, and members of ethics committees to stay up to date with clinical research and good practice developments. This article investigates the enormous value of quality assurance and control in clinical trials, highlighting their pivotal role in ensuring the integrity, safety, and efficacy of research findings.